- Home
- PHGE vs ATER Comparison
PHGE vs ATER Comparison
Compare PHGE & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- ATER
- Stock Information
- Founded
- PHGE 2015
- ATER 2014
- Country
- PHGE Israel
- ATER United States
- Employees
- PHGE N/A
- ATER N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- ATER Home Furnishings
- Sector
- PHGE Health Care
- ATER Consumer Discretionary
- Exchange
- PHGE Nasdaq
- ATER Nasdaq
- Market Cap
- PHGE 14.6M
- ATER 15.5M
- IPO Year
- PHGE N/A
- ATER N/A
- Fundamental
- Price
- PHGE $0.50
- ATER $1.48
- Analyst Decision
- PHGE Strong Buy
- ATER
- Analyst Count
- PHGE 2
- ATER 0
- Target Price
- PHGE $20.00
- ATER N/A
- AVG Volume (30 Days)
- PHGE 85.8K
- ATER 142.3K
- Earning Date
- PHGE 05-15-2025
- ATER 05-14-2025
- Dividend Yield
- PHGE N/A
- ATER N/A
- EPS Growth
- PHGE N/A
- ATER N/A
- EPS
- PHGE N/A
- ATER N/A
- Revenue
- PHGE N/A
- ATER $94,191,000.00
- Revenue This Year
- PHGE N/A
- ATER N/A
- Revenue Next Year
- PHGE N/A
- ATER $10.62
- P/E Ratio
- PHGE N/A
- ATER N/A
- Revenue Growth
- PHGE N/A
- ATER N/A
- 52 Week Low
- PHGE $0.45
- ATER $1.43
- 52 Week High
- PHGE $4.90
- ATER $3.84
- Technical
- Relative Strength Index (RSI)
- PHGE 40.96
- ATER 30.04
- Support Level
- PHGE $0.45
- ATER $1.43
- Resistance Level
- PHGE $0.52
- ATER $1.75
- Average True Range (ATR)
- PHGE 0.04
- ATER 0.16
- MACD
- PHGE -0.00
- ATER -0.03
- Stochastic Oscillator
- PHGE 39.31
- ATER 4.26
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.